BIRC5 and glioblastoma: A recent study also demonstrated that posaconazole, which has demonstrated antitumor activity for glioblastoma, inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in both in vitro and in vivo models of glioblastoma [10].